Long-term debt · 2019–2025

Phathom Pharmaceuticals long-term debt

$209M+3.8% · FY2025

Phathom Pharmaceuticals (PHAT) reported $209M in long-term debt for fiscal 2025, +3.8% year on year.

$22.8M2019$39.6M2020$89.7M2021$95.3M2022$138M2023$201M2024$209M2025
Phathom Pharmaceuticals — Long-term debt, 2019–2025
Fiscal yearLong-term debtChangeFiling
FY20252025-12-31$209M+3.8%Open →
FY20242024-12-31$201M+46.1%Open →
FY20232023-12-31$138M+44.7%Open →
FY20222022-12-31$95.3M+6.2%Open →
FY20212021-12-31$89.7M+126.2%Open →
FY20202020-12-31$39.6M+74.0%Open →
FY20192019-12-31$22.8M—Open →

Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +44.7%

Long-term debt at companies of similar size

Full ranking by long-term debt →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Phathom Pharmaceuticals long-term debt |url=https://companiesranked.com/en/company/phathom-pharmaceuticals/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Phathom Pharmaceuticals long-term debt. CompaniesRanked. https://companiesranked.com/en/company/phathom-pharmaceuticals/long-term-debt

BibTeX

@misc{companiesranked-en-company-phathom-pharmaceuticals-long-term-debt-2026,
  author       = {{CompaniesRanked}},
  title        = {{Phathom Pharmaceuticals long-term debt}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/phathom-pharmaceuticals/long-term-debt}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-324867 · July 30, 2026

{{cite web |title=Phathom Pharmaceuticals long-term debt — 10-Q (0001193125-26-324867) |url=https://www.sec.gov/Archives/edgar/data/1783183/000119312526324867/phat-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Phathom Pharmaceuticals overview